What types of inhaled therapies are recommended as part of the standard treatment protocol for cystic fibrosis?
Abstract
A variety of inhaled therapies, including antibiotics (e.g., tobramycin, aztreonam lysine), mucolytics (e.g., dornase alfa), and osmotic agents (e.g., hypertonic saline), are integral to managing respiratory conditions in cystic fibrosis as part of standard treatment protocols.
Fields of Study & Subjects
Cystic Fibrosis Research Advances
Inhalation and Respiratory Drug Delivery
Chronic Obstructive Pulmonary Disease (COPD) Research
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 19 January 2026